Quantcast
Last updated on April 18, 2014 at 6:20 EDT

Latest Oncology Stories

2014-03-31 08:29:56

BERGISCH GLADBACH, Germany, March 31, 2014 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) and the Paul Scherrer Institute (PSI) are announcing an extension of their existing collaboration in the field of proton therapy to offer patients more precise cancer treatments using intensity modulated proton therapy (IMPT). Under the agreement, Varian will also supply technology and equipment to help meet a growing demand for clinical research and treatments at PSI. Proton therapy...

2014-03-31 08:28:39

Patients in Ontario and Atlantic Canada face significant challenges accessing oral medications due to their age, cancer type and where they live TORONTO, March 31, 2014 /CNW/ - The CanCertainty Coalition - an unprecedented unification of more than 30 Canadian patient groups, physicians, and health charities today released a powerful video highlighting the significant challenges cancer patients in Ontario and Atlantic Canada face in accessing oral medications. The video's message...

2014-03-30 23:01:52

The Mesothelioma Applied Research Foundation released today videos of scientific and community sessions and speeches from the 2014 International Symposium on Malignant Mesothelioma. Alexandria, VA (PRWEB) March 30, 2014 Today, the Mesothelioma Applied Research Foundation (Meso Foundation) made available videos of sessions and presentations from its 2014 International Symposium on Malignant Mesothelioma. The videos feature an array of mesothelioma experts, including doctors, researchers,...

2014-03-29 23:01:54

A new study finds that a drug that kills bladder cancer cells with light works even better when another compound is added. Raleigh, NC (PRWEB) March 29, 2014 The Chinese developers of a light-based treatment for bladder cancer say the treatment can be improved with the addition of a second drug. Click here to read the findings, which have just been posted on the Cancer Monthly website. Doctors in the Department of Urology at Fudan University in Shanghai have concluded that the...

2014-03-28 23:24:07

In the April 9 webinar from Atlantic Information Services, participants will hear details of the innovative oncology management programs Aetna Inc. has launched, and the results their personalized, value-based initiatives have achieved thus far. Washington, DC (PRWEB) March 28, 2014 Although effective oncology management has been a high priority for payers for many years, recent developments in U.S. health care are presenting new opportunities for health plans. Some are working with...

2014-03-28 23:22:33

Two recent studies illustrate the danger of smoking, especially among diabetics who take insulin. Raleigh, NC (PRWEB) March 28, 2014 New research studies conducted in Taiwan and Turkey and reported by Cancer Monthly show that the risk of bladder cancer is exacerbated by smoking. The risk was even higher among diabetics who were on insulin. Evidence suggests that people with type 2 diabetes face a higher risk of bladder cancer than the general public (“Bladder Cancer and diabetes,”...

2014-03-28 23:04:53

Markets Research Reports.biz added deep and professional market research reports on "NSCLC Therapeutics In Asia-Pacific Markets To 2019 - Personalized Therapies Focus On Untapped Segment Of Squamous Cell Carcinoma To Expand Treatment Pool" Market Analysis and Overview. Visit: http://www.marketresearchreports.biz/analysis-details/nsclc-therapeutics-in-asia-pacific-markets-to-2019-personalized-therapies-focus-on-untapped-segment-of-squamous-cell-carcinoma-to-expand-treatment-pool....

2014-03-28 23:00:12

One woman’s successful fight against breast cancer becomes another person’s reason for hope and inspiration. New York (PRWEB) March 29, 2014 “Are You Kidding Me?” is about being diagnosed with breast cancer and all the wonderful games author Lucy Morrison got to play. It starts out with the mammogram and further testing and continues with surgery, radiation, and chemotherapy. She was fortunate to have a less-invasive type of cancer and did not need the kind of chemotherapy that...

2014-03-28 12:22:04

DUBLIN, Mar. 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/44vxfn/investigation ) has announced the addition of the "Investigation Report on China Imatinib Market, 2009-2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Incidence of chronic myelogenous leukemia (CML) varies in the world. The global incidence is about 10/1,000,000 while in China it is 4/1,000,000. CML takes up about 20% of leukaemia in China...

2014-03-28 12:21:55

DUBLIN, Mar. 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/cvsjq3/investigation ) has announced the addition of the "Investigation Report on China Pemetrexed Market, 2009-2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Pemetrexed, originally developed by Eli Lilly and Company, is a multi-targeted antimetabolite antitumor drug. This product is with huge growth potential in the market. Approved by FDA...